Posts by: Anna Tan, RN

Anna Tan, RN

Anna is responsible for the scripting and production of video news content. Her skills as a registered nurse as well as a proven video content creator on YouTube and other social media platforms allow her to create video news reports that are engaging and easy to understand for patients.

July 20, 2015November 6, 2015

AstraZeneca Signs Partnership With Kyowa Hakko Kirin To Commercialize Asthma and COPD Drug Benralizumab in Japan

Asthma, News

AstraZeneca announced last week it has signed into a partnership with Kyowa Hakko Kirin Co. Ltd. for exclusivity in commercializing benralizumab, a monoclonal antibody currently in Phase III clinical studies as potential ... Read more

July 16, 2015July 16, 2015

Traditional Chinese Exercise and Meditation Helps Senior COPD Patients

News

A new study entitled “Efficacy of Liuzijue Qigong in Individuals with Chronic Obstructive Pulmonary Disease in Remission” published in the Journal of the American Geriatrics Society suggests that chronic obstructive pulmonary disease ... Read more

July 16, 2015November 5, 2015

Boehringer Ingelheim Lauds 2015 IPF Treatment Guidelines for Recommending OFEV

Idiopathic Pulmonary Fibrosis, News

The recently published 2015 ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis – An Update of the 2011 Guideline, which recommends using OFEV® (nintedanib) to treat patients diagnosed with idiopathic pulmonary fibrosis ... Read more

July 14, 2015July 14, 2015

Iressa (gefitinib) Now FDA-Approved for Metastatic Lung Cancer

Lung Cancer, News

Iressa (gefitinib) by AstraZeneca Pharmaceuticals will soon be available as another first-line treatment option for patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are composed of certain types of epidermal ... Read more

July 10, 2015October 28, 2015

New FDA-approved COPD Biomarker Opens Doors to New Research

News

The COPD Foundation, a Washington D.C.- and Florida-based not-for-profit organization dedicated to supporting those living with this debilitating respiratory illness, has just announced that a novel clinical biomarker, plasma fibrinogen, has ... Read more

July 2, 2015November 6, 2015

Hair Samples May Help Shed Light on Asthma, Cortisol Levels and Pregnancy Complications

Asthma, News

A study presented during the 2015 AACC Annual Meeting & Clinical Lab Expo in Atlanta suggests that hair samples can be used to assess the effects of asthma on cortisol ... Read more

July 1, 2015November 9, 2015

COPD Treatment STIOLTO RESPIMAT Now Available Nationwide

COPD, News

Following the US Food and Drug Administration‘s final approval of Boehringer Ingelheim Pharmaceuticals, Inc.‘s STIOLTO™ RESPIMAT® (tiotropium bromide and olodaterol) Inhalation Spray in May 2015, the company recently announced that patients with ... Read more

February 6, 2015November 9, 2015

Study Reveals E-Cig Vapor Compromises Lung Immune Response

COPD, News

A new study, titled “Exposure to Electronic Cigarettes Impairs Pulmonary Anti-Bacterial and Anti-Viral Defenses in a Mouse Model,” led by Thomas Sussan, PhD, an assistant scientist in the Department of Environmental ... Read more

February 4, 2015November 9, 2015

Theravance and Mylan to Co-Develop Groundbreaking COPD Drug

COPD, News

Theravance Biopharma, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, central nervous system ... Read more

January 29, 2015November 5, 2015

First E-Nebulizer for Pulmozyme Now FDA-Approved for CF, Cuts Treatment Time to 2 Minutes

Cystic Fibrosis, News

Cystic fibrosis patients all over America will soon be able to take advantage of a new daily treatment method, as the US Food and Drug Administration has just granted final approval ... Read more